Home › NDC Lookup › RxCUI directory › RxCUI 994237

Aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule — RxCUI 994237

RxNorm drug concept · Semantic clinical drug
RxCUI 994237 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI994237
Official nameAspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
FDA products mapped4
Package NDCs mapped10
Reported Medicaid activity (SDUD)1,766 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
  • Why would someone use a rectal suppository instead of just taking aspirin by mouth?
  • First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
  • This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...
📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How Aspirin 325 MG / butalbital 50 MG / caffeine 40... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule RxCUI 994237

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Aspirin 1191
    • Butalbital 19860
    • Caffeine 1886
    • Codeine 2670
    • Aspirin / butalbital / caffeine / codeine 214160
    • Codeine phosphate 2672
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ascomp 1372693
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aspirin / butalbital / caffeine / codeine Oral Capsule 374756
    • Aspirin / butalbital / caffeine / codeine phosphate Oral Capsule 2647457
    • Aspirin / butalbital / caffeine / codeine Oral Product 1154056
    • Aspirin / butalbital / caffeine / codeine Pill 1154057
    • Aspirin / butalbital / caffeine / codeine phosphate Oral Product 2662204
    • Aspirin / butalbital / caffeine / codeine phosphate Pill 2661243
    • Aspirin / butalbital / caffeine / codeine Oral Capsule [Ascomp] 700585
    • Aspirin / butalbital / caffeine / codeine phosphate Oral Capsule [Ascomp] 2656451
    • +5 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aspirin 325 MG SCDC · 317300
  • Butalbital 50 MG SCDC · 317309
  • Caffeine 40 MG SCDC · 317310
  • Codeine phosphate 30 MG SCDC · 993780
  • Aspirin / butalbital / caffeine / codeine Oral Capsule SCDF · 374756
  • Aspirin / butalbital / caffeine / codeine phosphate Oral Capsule SCDFP · 2647457
  • Aspirin / butalbital / caffeine / codeine Oral Product SCDG · 1154056
  • Aspirin / butalbital / caffeine / codeine Pill SCDG · 1154057
  • Aspirin / butalbital / caffeine / codeine phosphate Oral Product SCDGP · 2662204
  • Aspirin / butalbital / caffeine / codeine phosphate Pill SCDGP · 2661243

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 994237 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51991-0074-01 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-01) Ascomp with Codeine Breckenridge Pharmaceutical, Inc. 2009-05-01
51991-0074-05 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-05) Ascomp with Codeine Breckenridge Pharmaceutical, Inc. 2009-05-01
63629-2952-01 30 CAPSULE in 1 BOTTLE (63629-2952-1) BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE Bryant Ranch Prepack 2021-12-22
63629-2952-02 20 CAPSULE in 1 BOTTLE (63629-2952-2) BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE Bryant Ranch Prepack 2021-12-22
63629-2952-03 90 CAPSULE in 1 BOTTLE (63629-2952-3) BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE Bryant Ranch Prepack 2010-03-30
63629-2952-04 60 CAPSULE in 1 BOTTLE (63629-2952-4) BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE Bryant Ranch Prepack 2010-03-30
63629-2952-05 40 CAPSULE in 1 BOTTLE (63629-2952-5) BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE Bryant Ranch Prepack 2014-09-26
63629-2952-06 18 CAPSULE in 1 BOTTLE (63629-2952-6) BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE Bryant Ranch Prepack 2021-12-22
69238-1993-01 100 CAPSULE in 1 BOTTLE (69238-1993-1) BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE Amneal Pharmaceuticals of New York, LLC 2019-04-01
79739-6094-01 100 CAPSULE in 1 BOTTLE (79739-6094-1) Ascomp with Codeine LGM PHARMA SOLUTIONS, LLC 2020-07-24
Observed labelers: Bryant Ranch Prepack (6) · Breckenridge Pharmaceutical, Inc. (2) · Amneal Pharmaceuticals of New York, LLC (1) · LGM PHARMA SOLUTIONS, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.0579
Range $1.0579–$1.0579 · middle 50% $1.0579–$1.0579 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.